Application of Differential Network Enrichment Analysis for Deciphering Metabolic Alterations

Modern analytical methods allow for the simultaneous detection of hundreds of metabolites, generating increasingly large and complex data sets. The analysis of metabolomics data is a multi-step process that involves data processing and normalization, followed by statistical analysis. One of the biggest challenges in metabolomics is linking alterations in metabolite levels to specific biological processes that are disrupted, contributing to the development of disease or reflecting the disease state. A common approach to accomplishing this goal involves pathway mapping and enrichment analysis, which assesses the relative importance of predefined metabolic pathways or other biological categories. However, traditional knowledge-based enrichment analysis has limitations when it comes to the analysis of metabolomics and lipidomics data. We present a Java-based, user-friendly bioinformatics tool named Filigree that provides a primarily data-driven alternative to the existing knowledge-based enrichment analysis methods. Filigree is based on our previously published differential network enrichment analysis (DNEA) methodology. To demonstrate the utility of the tool, we applied it to previously published studies analyzing the metabolome in the context of metabolic disorders (type 1 and 2 diabetes) and the maternal and infant lipidome during pregnancy.

[1]  J. Hayes,et al.  Glutathione and glutathione-dependent enzymes represent a co-ordinately regulated defence against oxidative stress. , 1999, Free radical research.

[2]  Monica Chagoyen,et al.  Tools for the functional interpretation of metabolomic experiments , 2013, Briefings Bioinform..

[3]  Jennifer L LaBarre,et al.  Maternal lipid levels across pregnancy impact the umbilical cord blood lipidome and infant birth weight , 2020, Scientific Reports.

[4]  Yaogang Wang,et al.  Triglyceride is an independent predictor of type 2 diabetes among middle-aged and older adults: a prospective study with 8-year follow-ups in two cohorts , 2019, Journal of Translational Medicine.

[5]  L. Liang,et al.  Association of Tryptophan Metabolites with Incident Type 2 Diabetes in the PREDIMED Trial: A Case-Cohort Study. , 2018, Clinical chemistry.

[6]  M. Karlsson,et al.  Model‐Based Prediction of Plasma Concentration and Enterohepatic Circulation of Total Bile Acids in Humans , 2018, CPT: pharmacometrics & systems pharmacology.

[7]  M. Kohzuki,et al.  Glutathione suppresses increase of serum creatine kinase in experimental hypoglycemia. , 2007, Diabetes research and clinical practice.

[8]  J. Brouwers,et al.  LION/web: a web-based ontology enrichment tool for lipidomic data analysis , 2018, bioRxiv.

[9]  I. Shechter,et al.  Regulation of rat liver 3-hydroxy-3-methylglutaryl coenzyme A reductase. Evidence for thiol-dependent allosteric modulation of enzyme activity. , 1984, Journal of Biological Chemistry.

[10]  John T. Wei,et al.  Metabolomic profiles delineate potential role for sarcosine in prostate cancer progression , 2009, Nature.

[11]  R. Tibshirani Regression Shrinkage and Selection via the Lasso , 1996 .

[12]  Svati H Shah,et al.  A branched-chain amino acid-related metabolic signature that differentiates obese and lean humans and contributes to insulin resistance. , 2009, Cell metabolism.

[13]  George Michailidis,et al.  Sparse network modeling and metscape‐based visualization methods for the analysis of large‐scale metabolomics data , 2017, Bioinform..

[14]  H. Hara,et al.  Plasma/Serum Plasmalogens: Methods of Analysis and Clinical Significance. , 2015, Advances in clinical chemistry.

[15]  P. Shannon,et al.  Cytoscape: a software environment for integrated models of biomolecular interaction networks. , 2003, Genome research.

[16]  Robert D. Leclerc Survival of the sparsest: robust gene networks are parsimonious , 2008, Molecular systems biology.

[17]  B. Horecker,et al.  International Symposium on Metabolism, Physiology, and Clinical Use of Pentoses and Pentitols , 2012, Springer Berlin Heidelberg.

[18]  R. Vasan,et al.  2-Aminoadipic acid is a biomarker for diabetes risk. , 2013, The Journal of clinical investigation.

[19]  M. Myśliwiec,et al.  The prognostic value of inflammatory and vascular endothelial dysfunction biomarkers in microvascular and macrovascular complications in type 1 diabetes. , 2019, Pediatric endocrinology, diabetes, and metabolism.

[20]  T. Asano,et al.  Role of Uric Acid Metabolism-Related Inflammation in the Pathogenesis of Metabolic Syndrome Components Such as Atherosclerosis and Nonalcoholic Steatohepatitis , 2016, Mediators of inflammation.

[21]  H. Zou,et al.  Group Lasso Penalized Learning Using a Unified BMD Algorithm [R package gglasso version 1.5] , 2020 .

[22]  H. Gilbert,et al.  Thiol/disulfide exchange between 3-hydroxy-3-methylglutaryl-CoA reductase and glutathione. A thermodynamically facile dithiol oxidation. , 1988, The Journal of biological chemistry.

[23]  D. Levy,et al.  Prognostic Utility of Novel Biomarkers of Cardiovascular Stress: The Framingham Heart Study , 2012, Circulation.

[24]  G. Ness,et al.  Regulation of the activity of 3-hydroxy-3-methylglutaryl coenzyme A reductase by insulin. , 1986, Biochemical and biophysical research communications.

[25]  Santo Fortunato,et al.  Consensus clustering in complex networks , 2012, Scientific Reports.

[26]  B. Staels,et al.  Bile Acid Sequestrants and the Treatment of Type 2 Diabetes Mellitus , 2012, Drugs.

[27]  W. Kannel,et al.  Diabetes and cardiovascular disease. The Framingham study. , 1979, JAMA.

[28]  J. Adamski,et al.  Cord Blood Lysophosphatidylcholine 16: 1 is Positively Associated with Birth Weight , 2018, Cellular Physiology and Biochemistry.

[29]  N. Mauras,et al.  Evidence for accelerated rates of glutathione utilization and glutathione depletion in adolescents with poorly controlled type 1 diabetes. , 2005, Diabetes.

[30]  David S. Wishart,et al.  HMDB 4.0: the human metabolome database for 2018 , 2017, Nucleic Acids Res..

[31]  T. Fenton,et al.  A systematic review and meta-analysis to revise the Fenton growth chart for preterm infants , 2013, BMC Pediatrics.

[32]  Atul J. Butte,et al.  Ten Years of Pathway Analysis: Current Approaches and Outstanding Challenges , 2012, PLoS Comput. Biol..

[33]  David S. Wishart,et al.  MSEA: a web-based tool to identify biologically meaningful patterns in quantitative metabolomic data , 2010, Nucleic Acids Res..

[34]  P. Njølstad,et al.  The kynurenine:tryptophan ratio as a predictor of incident type 2 diabetes mellitus in individuals with coronary artery disease , 2017, Diabetologia.

[35]  C. Wild Complementing the Genome with an “Exposome”: The Outstanding Challenge of Environmental Exposure Measurement in Molecular Epidemiology , 2005, Cancer Epidemiology Biomarkers & Prevention.

[36]  O. Vaarala Leaking gut in type 1 diabetes , 2008, Current opinion in gastroenterology.

[37]  M. Yuan,et al.  Model selection and estimation in regression with grouped variables , 2006 .

[38]  George Michailidis,et al.  Differential network enrichment analysis reveals novel lipid pathways in chronic kidney disease , 2019, Bioinform..

[39]  M. Patti,et al.  The role of mitochondria in the pathogenesis of type 2 diabetes. , 2010, Endocrine reviews.

[40]  Susan Cheng,et al.  Metabolite Profiling Identifies Pathways Associated With Metabolic Risk in Humans , 2012, Circulation.

[41]  R. Tibshirani,et al.  Sparse inverse covariance estimation with the graphical lasso. , 2008, Biostatistics.

[42]  A. Sonagra,et al.  Normal pregnancy- a state of insulin resistance. , 2014, Journal of clinical and diagnostic research : JCDR.

[43]  B. Staels,et al.  Role of bile acids and bile acid receptors in metabolic regulation. , 2009, Physiological reviews.

[44]  Tso-Jung Yen,et al.  Discussion on "Stability Selection" by Meinshausen and Buhlmann , 2010 .

[45]  Tom R. Gaunt,et al.  Metabolite profiling and cardiovascular event risk: a prospective study of 3 population-based cohorts. , 2015, Circulation.

[46]  J. Watkins,et al.  Diabetes, oxidative stress, and antioxidants: A review , 2003, Journal of biochemical and molecular toxicology.

[47]  A. Passaro,et al.  Plasma triglycerides predict ten-years all-cause mortality in outpatients with type 2 diabetes mellitus: a longitudinal observational study , 2014, Cardiovascular Diabetology.

[48]  Oliver Fiehn,et al.  LipidBlast - in-silico tandem mass spectrometry database for lipid identification , 2013, Nature Methods.

[49]  E. Levina,et al.  Joint estimation of multiple graphical models. , 2011, Biometrika.

[50]  Sara Ciucci,et al.  LIPEA: Lipid Pathway Enrichment Analysis , 2018, bioRxiv.

[51]  Matej Oresic,et al.  Metabolic Regulation in Progression to Autoimmune Diabetes , 2011, PLoS Comput. Biol..

[52]  V. Mootha,et al.  Metabolite profiles and the risk of developing diabetes , 2011, Nature Medicine.

[53]  H. İlkova,et al.  Effect of oxidative stress on glutathione pathway in red blood cells from patients with insulin-dependent diabetes mellitus. , 2002, Metabolism: clinical and experimental.

[54]  J Bruce German,et al.  Nutrigenomics and personalized diets: What will they mean for food? , 2011, Annual review of food science and technology.

[55]  L. Jovanovič,et al.  Birth weight as a predictor of type 2 diabetes mellitus: The U-shaped curve , 2001, Current diabetes reports.

[56]  Oliver Fiehn,et al.  Systemic alterations in the metabolome of diabetic NOD mice delineate increased oxidative stress accompanied by reduced inflammation and hypertriglyceremia. , 2015, American journal of physiology. Endocrinology and metabolism.

[57]  C. Borghi,et al.  Serum uric acid predicts incident metabolic syndrome in the elderly in an analysis of the Brisighella Heart Study , 2018, Scientific Reports.

[58]  David S. Wishart,et al.  Using MetaboAnalyst 4.0 for Comprehensive and Integrative Metabolomics Data Analysis , 2019, Current protocols in bioinformatics.

[59]  B. Staels,et al.  Bile Acid Metabolism and the Pathogenesis of Type 2 Diabetes , 2011, Current diabetes reports.

[60]  J. Gutierrez,et al.  Current Thoughts on Maternal Nutrition and Fetal Programming of the Metabolic Syndrome , 2013, Journal of pregnancy.

[61]  Ali Shojaie,et al.  Analysis of Gene Sets Based on the Underlying Regulatory Network , 2009, J. Comput. Biol..

[62]  I. Palacios,et al.  Metabolite Profiles Predict Acute Kidney Injury and Mortality in Patients Undergoing Transcatheter Aortic Valve Replacement , 2016, Journal of the American Heart Association.

[63]  E. Martínez-Victoria,et al.  Omega 3 polyunsaturated fatty acids and body weight , 2012, British Journal of Nutrition.

[64]  A. Larsson,et al.  Cholesterol synthesis in patients with glutathione deficiency , 1990, European journal of clinical investigation.

[65]  M. Rienstra,et al.  Metabolomic Profiling in Relation to New-Onset Atrial Fibrillation (from the Framingham Heart Study). , 2016, The American journal of cardiology.

[66]  C. Andrés-Lacueva,et al.  Nutrimetabolomic strategies to develop new biomarkers of intake and health effects. , 2012, Journal of agricultural and food chemistry.

[67]  I. Dotan,et al.  Thiol-disulfide-dependent interconversion of active and latent forms of rat hepatic 3-hydroxy-3-methylglutaryl-coenzyme A reductase. , 1982, Biochimica et biophysica acta.

[68]  J. Mathers,et al.  Diet induced epigenetic changes and their implications for health , 2011, Acta physiologica.

[69]  G. Michailidis,et al.  Network Enrichment Analysis in Complex Experiments , 2010, Statistical applications in genetics and molecular biology.

[70]  Christian Gieger,et al.  Metabolic Footprint of Diabetes: A Multiplatform Metabolomics Study in an Epidemiological Setting , 2010, PloS one.

[71]  A. Barabasi,et al.  Lethality and centrality in protein networks , 2001, Nature.

[72]  B. Koletzko,et al.  Placental MFSD2a transporter is related to decreased DHA in cord blood of women with treated gestational diabetes. , 2017, Clinical nutrition.

[73]  R. Viola,et al.  Obesity and the gut microbiota: does up-regulating colonic fermentation protect against obesity and metabolic disease? , 2011, Genes & Nutrition.

[74]  O. Fiehn,et al.  Diabetes associated metabolomic perturbations in NOD mice , 2014, Metabolomics.

[75]  T. Mak,et al.  Regulation of cancer cell metabolism , 2011, Nature Reviews Cancer.

[76]  E. Baraldi,et al.  Metabolomics reveals new metabolic perturbations in children with type 1 diabetes , 2018, Pediatric diabetes.

[77]  N. Meinshausen,et al.  Stability selection , 2008, 0809.2932.

[78]  Veena S. Kasture,et al.  International Journal of Research and Development in Pharmacy and Life Sciences Metabolomics: Current Technologies and Future Trends , 2022 .

[79]  Thomas J. Wang,et al.  Metabolomics insights into early type 2 diabetes pathogenesis and detection in individuals with normal fasting glucose , 2018, Diabetologia.

[80]  Shuzhao Li,et al.  Bioinformatics Tools for the Interpretation of Metabolomics Data , 2017, Current Pharmacology Reports.

[81]  P. Haggarty,et al.  Long-chain polyunsaturated fatty acid transport across the perfused human placenta. , 1997, Placenta.

[82]  J. Collins,et al.  Inferring Genetic Networks and Identifying Compound Mode of Action via Expression Profiling , 2003, Science.

[83]  Pablo Tamayo,et al.  Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[84]  J. Lakey,et al.  Human pancreatic islet beta-cell destruction by cytokines involves oxygen free radicals and aldehyde production. , 1996, The Journal of clinical endocrinology and metabolism.

[85]  M. Hediger,et al.  Small intestine hexose transport in experimental diabetes. Increased transporter mRNA and protein expression in enterocytes. , 1994, The Journal of clinical investigation.

[86]  S. Grundy,et al.  Effects of diabetes mellitus on cholesterol metabolism in man. , 1977, The New England journal of medicine.

[87]  E. Flagg,et al.  Glutathione in human plasma: decline in association with aging, age-related macular degeneration, and diabetes. , 1998, Free radical biology & medicine.

[88]  B. Kalyanaraman,et al.  Rapid and irreversible inhibition of creatine kinase by peroxynitrite , 1998, FEBS letters.

[89]  T. Kondo,et al.  Impairment of glutathione metabolism in erythrocytes from patients with diabetes mellitus. , 1989, Metabolism: clinical and experimental.

[90]  Hiroyuki Ogata,et al.  KEGG: Kyoto Encyclopedia of Genes and Genomes , 1999, Nucleic Acids Res..

[91]  Jiang He,et al.  Lipidomic Signature of Progression of Chronic Kidney Disease in the Chronic Renal Insufficiency Cohort , 2016, Kidney international reports.